Digital Therapeutics

Enterprises involving in Digital Therapeutics business

Shortly after the launch of Japan's first digital therapeutics in January 2021, the Life Science Group of Yano Research Institute published the first edition of its digital therapeutics (DTx) market report, Digital Therapeutics 2021. The timing was at the peak of anticipation for market formation.
By the time the third edition was published, however, the market was in a period of uncertainty after an American DTx company went bankrupt.
The timing of the publication of this latest, fourth edition coincides with disappointment. Some argue that DTx cannot generate revenue or procure funding, and that the returns do not justify the enormous risks. Yes, DTx may be difficult to monetize. However, DTx has not exactly lost its purpose.
The fourth edition provides business proposals by converging all the expertise from various surveys conducted by the Life Science Group of the Yano Research Institute, with a subtitle of "How to Monetize DTx-Related Businesses."

1. Current Status, Challenges, and Perspectives of Digital Therapeutics (DTx)

1.1 Definition of Digital Therapeutics (DTx)
　　1.1.1 Definition of DTx
　　1.1.2 Three Trends Regarding DTx
　　1.1.3 About Software as a Medical Device (SaMD)
　　1.1.4 Provisions Regarding SaMD under the Pharmaceuticals and Medical Devices Act
　　1.1.5 Status of Discussions on Institutional Aspects of DTx (Approval, Insurance Coverage, etc.)

1.2 Analysis of the DTx Market
　　1.2.1 Entire Picture of the DTx Market
　　1.2.2 Political, Economic, Socio-cultural, and Technological (PEST) Analysis as well as Industrial Habits (Communities)
　　1.2.3 Operational Sources to be Needed (Companies)
　　1.2.4 List of DTx Developers (Competitors) and Pipelines
　　1.2.5 DTx Acceptance Bases at Medical Institutions and Patients (Consumers)
　　1.2.6 The 4Ps and 4Cs in DTx
　　1.2.7 DTx Values

1.3 Size and Future Perspectives of the DTx Market
　　1.3.1 Forecast of DTx Market Launch
　　1.3.2 Analysis of DTx by Potential Market Size Estimation Factor, and Numerical Examples　　　　
　　1.3.3 Market Size Forecasts
　　1.3.4 DTx from the ROI (Return on Investment) Perspective
　　1.3.5 Future Perspectives of the DTx Market

2. Analysis of the DTx Market by Disease

2.0 Key Disease Areas for DTx
　　2.0.1 Disease Areas Experiencing Booming DTx Development
　　2.0.2 Market Backdrop
2.1 Diabetic
　　2.1.1 Market Environment (Number of Patients, Clinical Guidelines)
　　2.1.2 Trends Among Market Entrants and Related Companies
　　2.1.3 Analysis of Potential Market Size
2.2 Depression
　　2.2.1 Market Environment (Number of Patients, Clinical Guidelines)
　　2.2.2 Trends Among Market Entrants and Related Companies
　　2.2.3 Analysis of Potential Market Size
2.3 Insomnia
　　2.3.1 Market Environment (Number of Patients, Clinical Guidelines)
　　2.3.2 Trends Among Market Entrants and Related Companies
　　2.3.3 Analysis of Potential Market Size
2.4 Chronic Pain (e.g. Lumbago (Lower Back Pain), Headaches)
　　2.4.1 Market Environment (Number of Patients, Clinical Guidelines)
　　2.4.2 Trends Among Market Entrants and Related Companies
　　2.4.3 Analysis of Potential Market Size
2.5 Mild Cognitive Impairment (MCI)
　　2.5.1 Market Environment (Number of Patients, Clinical Guidelines)
　　2.5.2 Trends Among Market Entrants and Related Companies
　　2.5.3 Analysis of Potential Market Size
2.6 Cancers (Including Bread Cancers)
　　2.6.1 Market Environment (Number of Patients, Clinical Guidelines)
　　2.6.2 Trends Among Market Entrants and Related Companies
　　2.6.3 Analysis of Potential Market Size
2.7 Heart Failure, Heart Diseases
　　2.7.1 Market Environment and Market Entrants
　　2.7.2 Analysis of Potential Market Size

3. Analysis of the DTx Market by Therapy

3.1 Cognitive Behavioral Therapy (CBT)
　　3.1.1 What is CBT?
　　3.1.2 CBT Applicable Diseases and Market Entrants
　　3.1.3 Analysis of Potential Market Size
3.2 Diet Therapy
3.3 Exercise Therapy and Rehabilitation
3.4 DTx as a Solution Complementary to Pharmaceuticals

4. Company Profiles

• Almaprism Inc.
• BiPSEE Inc.
• CaTe Inc.
• CureApp, Inc.
• DT-Axis Co., Ltd.
• emol Inc.
• NTT DOCOMO, INC.
• Provigate, Inc.
• UT HealthTech Inc.
• Cure Code Corp.
• SUSMED, Inc.
• K.K. Social Service
• MED MIRAI, Inc.
• Remohab Inc.